Researcher
Daan Dierickx
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Hematology (Division)
Responsible
From1 Oct 2019 → Today - Laboratory of Experimental Hematology (Division)
Member
From1 Oct 2013 → Today
Projects
1 - 10 of 14
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GAINING INSIGHT IN THE MUTATIONAL PROFILE OF PT-DLBCL AND ASSESSING ITS BIOLOGICAL EFFECTS AND TRANSFORMING POTENTIALFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Degradation of CDK1 and HDACs as a strategy to treat T-cell malignanciesFrom1 Oct 2023 → TodayFunding: BOF - projects
- Characterization of non-canonical EZH2 transcriptional complexes to identify new therapeutic targets in peripheral T cell lymphoma.From1 Sep 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Extensive preclinical validation of combinations of targeted treatment for peripheral T cell lymphomaFrom10 Aug 2021 → 30 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development and validation of a novel platform for fast and easy diagnosis of von Willebrand diseaseFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
Publications
171 - 180 of 203
- The treatment of hematologic malignancies in pregnancy(2010)
Authors: Christophe Vandenbriele, Daan Dierickx, Frédéric Amant, Michel Delforge
Pages: 74 - 87 - Posttransplant malignancies and lymphoproliferative disorders(2009)
Authors: Daan Dierickx
Pages: 633 - 639 - Recipient-derived chronic lymphocytic leukaemia diagnosed shortly after kidney transplantation on protocol biopsy(2009)
Authors: Daan Dierickx, Peter Vandenberghe, Ann Janssens, Evelyne Lerut, Gregor Verhoef, Pieter Evenepoel
Pages: 3886 - 3890 - Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial(2009)
Authors: Ralf Trappe, Sylvain Choquet, Stephan HK Oertel, Veronique Leblond, Daan Dierickx, Peter Mollee, Monica Sender, Tor Ekman, Jan Maciej Zaucha, Petra Reinke, et al.
Pages: 46 - 46 - Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study(2009)
Authors: Daan Dierickx, Gregor Verhoef, Ann Janssens
Pages: 484 - 491 - Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation(2009)
Authors: Daan Dierickx
Pages: 2060 - 2067 - Hepatosplenic gamma delta T-Cell Lymphoma After Liver Transplantation: Report of the First 2 Cases and Review of the Literature(2009)
Authors: Philip Roelandt, Johan Maertens, Peter Vandenberghe, Chris Verslype, Tania Roskams, Raymond Aerts, Frederik Nevens, Daan Dierickx
Pages: 686 - 692 - A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA(2009)
Authors: Daan Dierickx
Pages: 429 - 429 - Viscerale leishmaniasis met hemofagocytaire lymfohistiocytose: casus en literatuuroverzicht(2009)
Authors: P Wallemacq, M Van Esbroeck, M Thomeer, Daan Dierickx, Steven Vanderschueren, Eric Van Wijngaerden
Pages: 570 - 574 - A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR-2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.(2008)
Authors: Daan Dierickx
Pages: 353 - 354